Jefferies lowers Kyowa Kirin stock rating to 'hold'
1 report, 1 independent
Updated Sep 1
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Jefferies Financial Group lowered the stock rating for Kyowa Kirin Co., Ltd. to 'hold' in a report published on September 8th. The company, a global biopharmaceutical firm based in Tokyo, specializes in innovative therapies. On September 1, the share price of Kyowa Kirin fell 0.7%, trading at a low of $14.40.
From tickerreport.com
Why it matters
The rating downgrade by Jefferies Financial Group affects market confidence in Kyowa Kirin. One analyst assigned a 'Hold' rating, while another analyst assigned a 'Sell' rating to the stock.
From tickerreport.com
Who's involved
- Kyowa KirinGlobal biopharmaceutical company headquartered in Tokyo, specializing in innovative therapies.
- Jefferies Financial GroupAmerican financial services company that issued the rating downgrade.
Keep exploring
The entities involved
-
Kyowa Kirin
pharmaceutical company
Nothing else this week.
-
Jefferies Financial Group
American financial services company